Will Stone

The basic idea is to force accreditation to be focused on the merit and the actual results that these universities are providing, as opposed to how woke these universities have gotten.

The basic idea is to force accreditation to be focused on the merit and the actual results that these universities are providing, as opposed to how woke these universities have gotten.

The basic idea is to force accreditation to be focused on the merit and the actual results that these universities are providing, as opposed to how woke these universities have gotten.

We believe that certain universities including, for example, Harvard have routinely violated this law and this law has not been effectively enforced.

We believe that certain universities including, for example, Harvard have routinely violated this law and this law has not been effectively enforced.

We believe that certain universities including, for example, Harvard have routinely violated this law and this law has not been effectively enforced.

Research on long COVID has settled on a handful of explanations for what could drive the illness, but that hasn't translated into major breakthroughs for those who need care. As many as 18 million adults are estimated to be living with long COVID in the U.S. Dr. Monica Verduzco-Gutierrez treats long COVID patients at UT Health Science Center San Antonio.

Research on long COVID has settled on a handful of explanations for what could drive the illness, but that hasn't translated into major breakthroughs for those who need care. As many as 18 million adults are estimated to be living with long COVID in the U.S. Dr. Monica Verduzco-Gutierrez treats long COVID patients at UT Health Science Center San Antonio.

There are now dozens of these trials testing drugs, but scientists say there need to be many more. Patient advocates say the federal government needs to make sure the millions of dollars set aside by Congress supports this type of long COVID research. Will Stone, NPR News.

There are now dozens of these trials testing drugs, but scientists say there need to be many more. Patient advocates say the federal government needs to make sure the millions of dollars set aside by Congress supports this type of long COVID research. Will Stone, NPR News.

A source with the Union for National Weather Service employees says more than 10 percent of staff in Alaska has been fired or left their jobs. They requested anonymity because they're not authorized to speak publicly. The cuts include meteorologists and support staff. The agency says it's been forced to stop launching weather balloons from the northwest Arctic community of Kotzebue.

A source with the Union for National Weather Service employees says more than 10 percent of staff in Alaska has been fired or left their jobs. They requested anonymity because they're not authorized to speak publicly. The cuts include meteorologists and support staff. The agency says it's been forced to stop launching weather balloons from the northwest Arctic community of Kotzebue.

Rick Thoman, a climatologist who worked for the Weather Service for more than 30 years, says the loss of 3D data about the atmosphere has wide-ranging effects.

Rick Thoman, a climatologist who worked for the Weather Service for more than 30 years, says the loss of 3D data about the atmosphere has wide-ranging effects.

Tommen worries that with key staff gone, weather station outages will be more frequent and last longer. For NPR News, I'm Eric Stone in Juneau.

Tommen worries that with key staff gone, weather station outages will be more frequent and last longer. For NPR News, I'm Eric Stone in Juneau.

Researchers have coalesced around a handful of explanations. There seem to be multiple underlying drivers of the illness, depending on the patient. One big focus has been the idea of viral persistence, that people never fully clear the infection. But there are others related to immune dysfunction, blood clots, the reactivation of other viruses.

Researchers have coalesced around a handful of explanations. There seem to be multiple underlying drivers of the illness, depending on the patient. One big focus has been the idea of viral persistence, that people never fully clear the infection. But there are others related to immune dysfunction, blood clots, the reactivation of other viruses.

Researchers have coalesced around a handful of explanations. There seem to be multiple underlying drivers of the illness, depending on the patient. One big focus has been the idea of viral persistence, that people never fully clear the infection. But there are others related to immune dysfunction, blood clots, the reactivation of other viruses.

These could ultimately trigger symptoms like brain fog, like fatigue, shortness of breath, something called post-exertional malaise. The challenge here remains translating some of these insights into treatment. There are still no approved drugs for long COVID. The approach is often to manage symptoms and try to improve quality of life. And what are the challenges in coming up with the treatment?